Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
RMD

RMD - ResMed Inc Stock Price, Fair Value and News

$257.72+2.22 (+0.87%)
Market Closed

59/100

RMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

59/100

RMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$256.17

Target 3M

$253.39

Target 6M

$254.15

RMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RMD Price Action

Last 7 days

-0.6%

Last 30 days

6.1%

Last 90 days

2.2%

Trailing 12 Months

3.1%

RMD RSI Chart

RMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RMD Valuation

Market Cap

37.6B

Price/Earnings (Trailing)

26.16

Price/Sales (Trailing)

7.16

EV/EBITDA

18.6

Price/Free Cashflow

21.27

RMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$256.17

Target 3M

$253.39

Target 6M

$254.15

RMD Fundamentals

RMD Revenue

Revenue (TTM)

5.3B

Rev. Growth (Yr)

9.07%

Rev. Growth (Qtr)

-0.92%

RMD Earnings

Earnings (TTM)

1.4B

Earnings Growth (Yr)

11.94%

Earnings Growth (Qtr)

-8.21%

RMD Profitability

EBT Margin

33.11%

Return on Equity

23.49%

Return on Assets

17.31%

Free Cashflow Yield

4.7%

RMD Investor Care

Dividend Yield

0.85%

Dividend/Share (TTM)

2.19

Buy Backs (1Y)

0.57%

Diluted EPS (TTM)

9.77

RMD Alerts

  • 3 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20255.0B5.1B5.3B0
20244.6B4.7B4.8B4.9B
20234.0B4.2B4.4B4.5B
20223.5B3.6B3.6B3.8B
20213.1B3.2B3.3B3.4B
20202.9B3.0B3.0B3.1B
20192.5B2.6B2.7B2.8B
20182.3B2.3B2.4B2.5B
20172.0B2.1B2.1B2.2B
20161.8B1.8B1.9B2.0B
20151.6B1.7B1.7B1.7B
20141.6B1.6B1.6B1.6B
20131.5B1.5B1.5B1.5B
20121.3B1.4B1.4B1.4B
20111.2B1.2B1.3B1.3B
20100001.2B
Get all data in R, Python etc through our Historical Stock Data APIs

About ResMed Inc

RMD
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
 CEO
 WEBSITEresmed.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES10140

ResMed Inc Frequently Asked Questions

RMD is the stock ticker symbol of ResMed Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of ResMed Inc is 37.62 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check RMD's fair value in chart for subscribers.

The fair value guage provides a quick view whether RMD is over valued or under valued. Whether ResMed Inc is cheap or expensive depends on the assumptions which impact ResMed Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RMD.

As of Wed Jan 28 2026, RMD's PE ratio (Price to Earnings) is 26.16 and Price to Sales (PS) ratio is 7.16. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RMD PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, ResMed Inc has provided 0.164 (multiply by 100 for percentage) rate of return.